Zdrowie i gospodarka · 16/09/2002

FDA Announces Submission of Information Collection for Unapproved/New Uses of Marketed Drugs, Biologics, and Devices

The Food and Drug Administration (FDA) is requesting public comment on the proposed collection of information related to the dissemination of information on unapproved or new uses for marketed drugs, biologics, and devices, which has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.